A Pilot Study of Probiotic Saccharomyces Boulardii Use in Chronic Heart Failure Patients. Estudo PROICA

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the feasibility, safety and effects in inflammatory response of the therapy with a probiotic agent, the yeast Saccharomyces boulardii (SB), in chronic heart failure patients.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universidade Federal Fluminense

Criteria

Inclusion Criteria:

• Class I or II (NYHA)heart failure patients

Exclusion Criteria:

• Corticosteroid use within 30 days

• NSAID use within 30 days

• Antibiotic use within 30 days

• Acute infections

• Inflammatory diseases

• Autoimmune diseases

• Cancer

• Intestinal diseases

• Chronic renal failure